SCHEMBL7200696

SCHEMBL7200696

Clc1ncnc2cc(I)ccc12.O=c1[nH]cnc2cc(I)ccc12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 11/20 0.57
ALDH1A1 P00352 1/20 0.57
PIM1 P11309 3/20 0.50
CHEK1 O14757 2/20 0.50
RPS6KA3 P51812 2/20 0.50
PDPK1 O15530 1/20 0.44
CA12 O43570 1/20 0.44
ALOX15 P16050 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
CA9 Q16790 1/20 0.44
TNKS2 Q9H2K2 1/20 0.44
PIK3CD O00329 1/20 0.41
PIK3CA P42336 1/20 0.41
PIK3CB P42338 1/20 0.41
KDM4A O75164 1/20 0.41
KDM4B O94953 1/20 0.41
KDM5C P41229 1/20 0.41
KDM4C Q9H3R0 1/20 0.41
KDM5B Q9UGL1 1/20 0.41
KDM3A Q9Y4C1 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL144026 0.87 PARP1 (0.74) PARP1ALDH1A1PIM1CHEK1RPS6KA3
SCHEMBL145141 0.83 PDE4A (0.53) PARP1ALDH1A1CHEK1PDE4APDE4B
SCHEMBL7200691 0.83 PARP1 (0.40) PARP1ALDH1A1PIM1CHEK1RPS6KA3
SCHEMBL643424 0.74 ALDH1A1 (1.00) PARP1ALDH1A1PIM1CHEK1RPS6KA3
SCHEMBL29701199 0.74 PARP1 (1.00) PARP1ALDH1A1PIM1CHEK1PDPK1
SCHEMBL29898482 0.74 ALDH1A1 (1.00) PARP1ALDH1A1PIM1CHEK1RPS6KA3
SCHEMBL216176 0.74 PARP1 (1.00) PARP1ALDH1A1PIM1CHEK1PDPK1
SCHEMBL4083037 0.73 ALDH1A1 (0.45) PARP1ALDH1A1PIM1CHEK1RPS6KA3
Ethoxycarbonyl Group SCHEMBL27863135 0.72 PARP1 (0.54) PARP1ALDH1A1PIM1CHEK1RPS6KA3
SCHEMBL29390639 0.70 PDE4A (0.53) PARP1ALDH1A1SMN1; SMN2PDE4APDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1353693-A2 PHARMACEUTICAL COMBINATION CONTAINING A 4-QUINAZOLINEAMINE AND ANOTHER ANTI-NEOPLASTIC AGENT FOR THE TREATMENT OF CANCER GLAXO GROUP LIMITED (GB) 2003-10-22 EP disclosed
WO-2002056912-A2 PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF CANCER CONTAINING A 4-QUINAZOLINEAMINE AND ANOTHER ANTI-NEOPLASTIC AGENT GLAXO GROUP LIMITED (GB) 2002-07-25 WO disclosed